Ben Tre Pharmaceutical
Bepharco is a Vietnamese pharmaceutical manufacturer and distributor founded in 1963, producing and distributing 250+ prescription medicines, health supplements, and medical devices through ETC hospital and OTC pharmacy channels to 35,000+ customers across 34 provinces in Vietnam.
- Company typePrivate
- Founded1963
- HeadquartersBen Tre, Vietnam
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ben Tre Pharmaceutical does
Ben Tre Pharmaceutical Joint Stock Company (Bepharco, legal name Công ty Cổ phần Dược phẩm Bến Tre) is a privately held Vietnamese pharmaceutical manufacturer and distributor founded in 1963 as the Pharmacy Preparation Room of the Ben Tre People's Health Committee. Operating from a registered head office in Vinh Long with an executive office in Ho Chi Minh City and a Central Highlands regional branch established in 2023, the company produces and distributes a portfolio of approximately 250 products across three categories: prescription medicines, health supplements, and medical devices. Therapeutic coverage spans cardiovascular, respiratory, gastrointestinal, neurological, musculoskeletal, anti-infective, endocrine, and psychiatric conditions, plus traditional herbal remedies such as Cảm Xuyên Hương Yen Bai that have been on the Vietnamese market for over 45 years.
The company's underlying technology base centers on WHO-GMP certified manufacturing executed primarily through partner facilities — including YPHARCO (Yen Bai Pharmaceutical), Nha Trang Vaccines and Biologicals, Meyer-BPC joint venture, and Raptakos Brett — while Bepharco owns the distribution, brand, and registration assets. Exclusive distribution of specialty originator drugs such as Gedeon Richter's Reagila (Cariprazine) adds a higher-value pharmaceutical layer atop the generic and herbal core. Products include small-molecule generics (Bisoprolol, Desloratadine, Meloxicam, Diclofenac), probiotics (Bacillus subtilis, Bacillus clausii), vitamins and supplements (Vitamin D3, liver detox, men's health), and isotonic/hypertonic seawater nasal sprays.
Bepharco's revenue model is built on unit sale of pharmaceutical SKUs through two parallel channels: an Ethical (ETC) channel where field medical representatives sell prescription products to hospitals, clinics, and healthcare facilities, and an Over-the-Counter (OTC) channel where pharmacy-focused representatives and supervisors distribute OTC medicines, supplements, and medical devices to chain pharmacies, independent pharmacies, and retail drugstores. The commercial operation reaches 35,000+ customer touchpoints across 34 provinces and cities in Vietnam, with pricing conducted via direct inquiry rather than public disclosure. The company supplements organic distribution with strategic partnerships (Gedeon Richter, Hyundai Bioscience), academic alliances for pharmacist development, and a wholly-owned subsidiary (Bepharco Healthcare JSC) established in 2022.
Ben Tre Pharmaceutical firmographics
Firmographics- Name
- Ben Tre Pharmaceutical
- Legal name
- Công ty Cổ phần Dược phẩm Bến Tre
- Website
- https://bepharco.com
- Company type
- Private
- Founded year
- 1963
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bepharco is a Vietnamese pharmaceutical manufacturer and distributor founded in 1963, producing and distributing 250+ prescription medicines, health supplements, and medical devices through ETC hospital and OTC pharmacy channels to 35,000+ customers across 34 provinces in Vietnam.
- Ownership category
- akta.pro rank
Ben Tre Pharmaceutical industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242), Medicinal and Botanical Manufacturing (325411)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industries
- OTC & Consumer Health Distributors (HLAIAJAC), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)
Keywords
Where Ben Tre Pharmaceutical is headquartered
LocationHeadquarters
- HQ city
- Ben Tre
- HQ country
- Vietnam
- HQ region
- Asia
Offices3 records
Markets served
Ben Tre Pharmaceutical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Pharmaceutical Product Sales (Prescription Medicines): Revenue is generated from the sale of prescription medicines (thuốc) across therapeutic categories including cardiovascular, anti-infective, neurological, respiratory, gastrointestinal, and musculoskeletal treatments. Products are sold to hospitals, clinics, and dispensed through pharmacy channels.
- OTC Medicines and Health Supplements: Sale of over-the-counter medicines and health supplements (thực phẩm bảo vệ sức khỏe) through pharmacy chains, independent pharmacies, and retail outlets across Vietnam's 34 provinces.
- Medical Devices Distribution: Distribution of medical devices including nasal sprays (Free Nose isotonic/hypertonic seawater products) and other medical equipment through pharmaceutical distribution channels.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Ben Tre Pharmaceutical product offering
Product offeringCore offering
Ben Tre Pharmaceutical Joint Stock Company (Bepharco) manufactures and distributes a portfolio of 250+ pharmaceutical products spanning prescription medicines, OTC remedies, health supplements, traditional herbal formulations and medical devices. The company operates through ETC (Ethical) and OTC distribution channels serving hospitals, clinics and pharmacies across 34 provinces in Vietnam, with 35,000+ customer touchpoints.
Product overview
Ben Tre Pharmaceutical Joint Stock Company (Bepharco) is a Vietnamese pharmaceutical company that manufactures and distributes medicines, health supplements, and medical devices. Founded in 1963, the company offers a portfolio of approximately 250 products across three main categories: prescription medicines (Thuốc) including cardiovascular drugs, antibiotics, anti-inflammatory medications, and psychiatric treatments; health supplements (Thực phẩm bảo vệ sức khỏe) including probiotics, herbal supplements, and vitamins; and medical devices (Trang thiết bị y tế) including nasal sprays. The company distributes products through hospital, clinic, and pharmacy networks nationwide, serving approximately 35,000 customers across 34 provinces in Vietnam. Key products include LISONORM MEZO for hypertension, BECOLORAT for allergies, BIOSUBTYL-II for digestive health, REAGILA for schizophrenia, VITALINK D3 supplements, and FREE NOSE seawater nasal sprays. The company also manufactures traditional herbal remedies such as CẢM XUYÊN HƯƠNG which has been trusted for over 45 years.
Differentiator
Problem solved
Functional benefit
Products and services
- CẢM XUYÊN HƯƠNG (Vien nang) Traditional cold remedy combining six herbal flavors including Ligusticum wallichii, Angelica dahurica and Cyperus rotundus, used for runny nose and flu symptoms. Manufactured by partner Ypharco.
- BISOTEXA 10 MG Cardiovascular prescription medicine containing Bisoprolol fumarate 10mg for treatment of essential hypertension and angina. Sold to hospitals and pharmacies via ETC and OTC channels.
- LISONORM MEZO Combination prescription medicine containing Amlodipine 5mg and Lisinopril 20mg for essential hypertension treatment. Sold to hospitals and pharmacies.
- REAGILA 6mg Original atypical antipsychotic containing Cariprazine 6mg for treatment of schizophrenia in adults. Distributed exclusively in Vietnam via the ETC channel.
- BECOLORAT 30ml Anti-allergy medication containing Desloratadine 2.5mg per 5ml for allergic rhinitis symptoms including sneezing, runny nose and itching.
- BIOSUBTYL-II 1g Probiotic supplement containing Bacillus subtilis for treatment of diarrhea, constipation, acute and chronic enteritis and digestive disorders.
- ENTEROGOLDS CHAI Probiotic supplement containing Bacillus clausii 2 billion spores for restoration of intestinal microflora and treatment of digestive disorders.
- Becolugel Antacid medication containing Aluminium phosphate gel 20% for treatment of pain, burning sensation and discomfort caused by stomach acid.
- BEFADOL Kid gói 5 ml Pediatric analgesic and antipyretic suspension containing Paracetamol 150mg per 5ml for fever reduction and pain relief in children.
- MELOXICAM NSAID anti-inflammatory medication containing Meloxicam 7.5mg for long-term treatment of chronic arthritis, primary dysmenorrhea and acute or chronic pain.
- BATIVIV Anti-diarrheal medication containing Bismuth subsalicylate 262mg for treatment of diarrhea, H. pylori infection and gastric ulcers.
- SIRO LANGGA Traditional herbal tonic for low blood pressure, poor appetite, fatigue, headache and dizziness, containing multiple herbal ingredients including Ginseng and Angelica.
- AMAKING Health supplement supporting male sexual health with herbal extract blend and L-Arginine 150mg.
- BỔ THẬN YB Herbal supplement supporting kidney function and reducing symptoms of frequent urination, containing Dioscorea and other traditional herbs.
- GIẢI ĐỘC GAN YB Liver detoxification supplement containing Cà gai leo extract 100mg, supporting liver protection and relief of skin condition symptoms.
- GESPRO FILORY Probiotic supplement containing 9 strains of lactic acid bacteria including Bifidobacterium and Lactobacillus species, plus FOS and vitamins.
- VITALINK D3 DROPS Vitamin D3 supplement for children from 1 year old and adults, containing Cholecalciferol 5µg (200 IU) per drop in olive oil.
- FREE NOSE Isotonic Seawater Nasal Spray Nasal spray with isotonic seawater (Sodium chloride 0.9%) for daily nasal hygiene and treatment of rhinosinusitis.
- FREE NOSE Hypertonic Seawater Nasal Spray Nasal spray with hypertonic seawater (Sodium chloride 2.2%) for nasal congestion and sinus infections, indicated for children from 3 months and adults.
- HEXSPAN
Quantifiable outcome
- 35,000+ healthcare facility customers served nationwide
- +3 more outcomes
Companies that use Ben Tre Pharmaceutical
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Ben Tre Pharmaceutical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Ben Tre Pharmaceutical partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered flagship, minor and core.
- Hyundai BioscienceflagshipBepharco signed a Memorandum of Understanding (MOU) with Hyundai Bioscience during the Vietnam-Korea Economic Forum 2026. The partnership aims at strategic cooperation in the pharmaceutical sector, potentially involving technology transfer, product development, or market expansion in Vietnam and Korea.
- Trường Dược – Đại học Y Dược TP.HCM (Ho Chi Minh City University of Medicine and Pharmacy - School of Pharmacy)minorBepharco partnered with the School of Pharmacy at Ho Chi Minh City University of Medicine and Pharmacy to support pharmacist training and education. The partnership aims to elevate the training of future pharmacists and strengthen the healthcare professional pipeline.
- Gedeon Richter (Hungary)coreBepharco is the exclusive distribution partner of Gedeon Richter's Reagila (Cariprazine) drug in Vietnam. Reagila is an original atypical antipsychotic developed in Hungary for the treatment of schizophrenia and bipolar disorder. Bepharco's mission includes bringing the best products for health to Vietnam through exclusive partnerships with international pharmaceutical companies.
- Công ty Cổ phần Vắc Xin và Sinh phẩm Nha Trang (Nha Trang Vaccines and Biologicals JSC)coreNha Trang Vaccines and Biologicals Joint Stock Company manufactures several Bepharco distributed products including BIOSUBTYL-II (Bacillus subtilis probiotic) and ENTEROGOLDS (Bacillus clausii probiotic). Bepharco distributes these products under its brand through its nationwide commercial network.
- Công ty liên doanh Meyer-BPCcoreMeyer-BPC joint venture company manufactures several products distributed by Bepharco including MELOXICAM 7.5mg tablets (anti-inflammatory, analgesic). The joint venture combines manufacturing capabilities with Bepharco's distribution network.
- YPHARCO (Công ty Cổ phần Dược phẩm Yên Bái)coreYen Bai Pharmaceutical Joint Stock Company manufactures traditional herbal medicines distributed by Bepharco including Cam Xuyen Huong Yen Bai, BỔ TỲ syrup, and CẢM CÚM - HO YBA. YPHARCO was the first factory among 14 northern midland and mountainous provinces to meet WHO-GMP standards.
- Raptakos BrettminorRaptakos Brett distributes CALCREM 15G (Clotrimazole antifungal cream) and SILVIRIN (Silver sulphadiazine cream) through Bepharco's commercial network. Bepharco serves as the local distributor for these products in Vietnam.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
Ben Tre Pharmaceutical competitors and assessment
Company assessmentEmerging players
- Hyundai Bioscience Co., Ltd. South Korean biotech with whom Bepharco signed a 2026 MOU for strategic pharmaceutical cooperation. Comparable as a counterparty in the same cross-border pharma-distribution ecosystem Bepharco operates in.
Direct peers
- OPC Pharmaceutical JSC: Vietnamese pharmaceutical company with strong positions in Western and traditional medicines, plus OTC consumer health. Comparable to Bepharco across therapeutic breadth and the ETC/OTC channel split.
- Mekophar Chemical Pharmaceutical JSC: Vietnamese pharmaceutical manufacturer producing generics, antibiotics and traditional medicines. Comparable mid-cap domestic peer with overlapping hospital and pharmacy channels and similar dependence on national distribution reach.
- Traphaco JSC: Leading Vietnamese pharmaceutical company with a strong traditional herbal medicine and consumer health brand portfolio (e.g., Boganic, Hoạt huyết dưỡng não). Highly comparable to Bepharco given overlapping OTC/herbal focus and nationwide pharmacy distribution.
- Imexpharm Corporation JSC: Vietnamese pharma manufacturer-distributor with EU-GMP certified plants and a portfolio spanning antibiotics, cardiovascular and OTC products. Comparable to Bepharco as a domestic producer-distributor serving hospital and pharmacy channels.
- Domesco Medical Import Export JSC: Vietnamese pharmaceutical company focused on generic medicines, OTC products and health supplements with nationwide distribution. Operates in the same ETC/OTC dual-channel model and comparable therapeutic categories as Bepharco.
- Pymepharco JSC: Vietnamese pharmaceutical manufacturer-distributor producing generic and specialty medicines for domestic and export markets. Comparable in product mix (generics + specialty) and in operating ETC/OTC channels through field sales and pharmacy distribution.
- DHG Pharma (Hau Giang Pharmaceutical JSC): One of Vietnam's largest domestic pharmaceutical manufacturers and distributors with a broad generic and OTC portfolio. Directly comparable to Bepharco as a vertically integrated Vietnamese pharma company serving hospitals and pharmacies nationwide.
Broad incumbents
- Sanofi Vietnam: Vietnamese subsidiary of global pharmaceutical major Sanofi, operating in both prescription and consumer health (e.g., vaccines, cardiovascular, OTC). Comparable as a multinational competitor/distributor targeting the same hospital and pharmacy channels in Vietnam.
- Gedeon Richter Plc: Hungarian multinational pharmaceutical company that is Bepharco's principal specialty partner (Reagila/Cariprazine exclusive distribution). Comparable as a broader originator whose branded specialty products Bepharco distributes in Vietnam.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Ben Tre Pharmaceutical social profiles
Digital presenceBen Tre Pharmaceutical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ben Tre Pharmaceutical leadership team
Management profileNumber of profiles
Ben Tre Pharmaceutical subsidiaries and ownership
Company hierarchySubsidiaries2 records
Ben Tre Pharmaceutical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ben Tre Pharmaceutical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ben Tre Pharmaceutical
What does Ben Tre Pharmaceutical do?
Ben Tre Pharmaceutical Joint Stock Company (Bepharco) manufactures and distributes a portfolio of 250+ pharmaceutical products spanning prescription medicines, OTC remedies, health supplements, traditional herbal formulations and medical devices. The company operates through ETC (Ethical) and OTC distribution channels serving hospitals, clinics and pharmacies across 34 provinces in Vietnam, with 35,000+ customer touchpoints.
Is Ben Tre Pharmaceutical a public or private company?
Ben Tre Pharmaceutical is a private company. It is classified as unknown and is currently operating.
When was Ben Tre Pharmaceutical founded?
Ben Tre Pharmaceutical was founded in 1963. It employs 11 to 50 people.
Where is Ben Tre Pharmaceutical based?
Ben Tre Pharmaceutical is headquartered in Ben Tre, Vietnam, in the Asia region.
How does Ben Tre Pharmaceutical make money?
Three revenue lines are on record. Pharmaceutical Product Sales (Prescription Medicines) is the primary driver. The others are OTC Medicines and Health Supplements and medical Devices Distribution.
Who are Ben Tre Pharmaceutical's main competitors?
Hyundai Bioscience Co., Ltd. is listed as an emerging player. Direct peers are OPC Pharmaceutical JSC, Mekophar Chemical Pharmaceutical JSC, Traphaco JSC, Imexpharm Corporation JSC, Domesco Medical Import Export JSC, Pymepharco JSC and DHG Pharma (Hau Giang Pharmaceutical JSC). Broad incumbents are Sanofi Vietnam and Gedeon Richter Plc.
Does Ben Tre Pharmaceutical have an API?
No public API is recorded for Ben Tre Pharmaceutical.
What industry is Ben Tre Pharmaceutical in?
Ben Tre Pharmaceutical's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIAJAC, OTC & Consumer Health Distributors. Its NAICS code is 424210 and its SIC code is 5122.